Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$8.36 - $21.08 $1.67 Million - $4.22 Million
-200,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$17.57 - $28.95 $3.51 Million - $5.79 Million
200,000 New
200,000 $4.08 Million
Q1 2021

May 17, 2021

SELL
$27.92 - $52.5 $3.39 Million - $6.38 Million
-121,562 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$19.0 - $57.61 $2.31 Million - $7 Million
121,562 New
121,562 $6.37 Million

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $157M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.